Sumanirole maleate (PNU-95666E) is a selective, high-affinity dopamine D2 receptor full agonist (ED50 = 46 nM). It has been utilized in research models of Parkinsons disease to study motor improvement and is a compound of interest for investigating the pathophysiology of restless legs syndrome.